• Study Resource
  • Explore
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
Nasal Drug Delivery in EMS
Nasal Drug Delivery in EMS

... The ambulance responds to an unconscious, barely breathing patient with obvious intravenous drug needle marks on both arms – consistent with heroin overdose  After an IV is established, naloxone (Narcan) is administered and the patient is successfully resuscitated.  Unfortunately, the medic suffe ...
PSYC 200 Chapter 3
PSYC 200 Chapter 3

... then differentiation and specialization occur. • Cells change from being stem cells, those from which any other specialized type of cell can form, to being only one kind of cell. ...
Use in hepatic Impairment: Monoamine oxidase Inhibitors: Children
Use in hepatic Impairment: Monoamine oxidase Inhibitors: Children

... should commence at 25mg/day increasing to 50mg/day after 1 week. Subsequent doses may be increased in case of lack ot response in 50mg/day increments up to 200mg/day as needed. However, the generally lower body weights of children compared to adults should be taken into consideration in advancing th ...
FDA Issues Complete Response Letter to
FDA Issues Complete Response Letter to

... today announced that it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for the investigational drug ILUVIEN®. The FDA issued the CRL to communicate its decision that the NDA cannot be approved in its present form. T ...
ONO Announces Results from Phase 1/2 and Phase 3 Clinical
ONO Announces Results from Phase 1/2 and Phase 3 Clinical

... The results showed that the percentage of patients achieving serum iPTH management level within 60-240 pg/mL (recommended by JSDT guideline*) at 85 days after the first dose of study drug, the primary endpoint, was significantly higher in the etelcalcetide group (59.0%) than in the placebo group (1. ...
Species PwrPnt
Species PwrPnt

... – Radiation and certain chemicals ...
Now - Diazon Pharmaceuticals
Now - Diazon Pharmaceuticals

... microtubule dynamics compared to other vinca binding compounds. Binding results in unique effects on microtubule curvature, translating into mechanisms that preserve the microtubule integrity of neurons and non-dividing cells, compared to current anti-mitotic drugs. DZ-2384 is being developed by Dia ...
Dosing bumex in relation to lasix
Dosing bumex in relation to lasix

... Overview. Potassium is a very important mineral for the proper function of all cells, tissues, and organs in the human body. It is also an electrolyte, a substance. Inappropriate dosing in patients with chronic TEENney disease can cause toxicity or ineffective therapy. In particular, older patients ...
Safety of Medicines - World Health Organization
Safety of Medicines - World Health Organization

genes
genes

... characteristic of an organism produced by the interaction between its genotype and the environment ...
The Complexity of Herb-Drug Interaction Research
The Complexity of Herb-Drug Interaction Research

... Golden seal had no effect on drug levels of indinavir in a clinical study6 with volunteers.§ Example 3: Herb-Drug Interaction? – Some but not all Trials controlled for the dosage† Midazolam, alprazolam and nifedipine are metabolised mainly by CYP3A4. Ginkgo decreased drug levels of and exposure to m ...
Drug Inter. - Dr.
Drug Inter. - Dr.

... Cytochrome P450 Definition Cytochrome P450 enzymes are a superfamily of more than 160 known members that play a major role in the metabolism a wide array of xenobiotics including drugs, chemical carcinogens, insecticides, petroleum products, and other environmental pollutants. ...
Food/Nutrient Effects on Drugs
Food/Nutrient Effects on Drugs

... X-chromosome-linked Can lead to neonatal jaundice, hemolytic anemia or acute hemolysis Most common in African, Middle Eastern, and Southeast Asians Also called favism Fava beans or pollen, Vitamin K or Vitamin C can cause hemolysis ...
Uses of Genomic Information in the Diagnosis of Disease
Uses of Genomic Information in the Diagnosis of Disease

...  All humans have 99.9% identical genetic makeup  The remaining 0.1% difference may provide useful information about diseases  The goal of genetics is to show why some people get sick from certain infections and environmental changes while others do not. ...
10-Drug Eruptions
10-Drug Eruptions

... -Usually occurs 2-6 weeks after initiation of the medication, which is later than most drug eruptions. -Treatment is supportive. ...
DEBATE: What should be our end-points of therapy? Pro: The
DEBATE: What should be our end-points of therapy? Pro: The

... required aspect of new drug development • The patient perspective: “How does it make me feel?” – FDA: always relevant and should be assessed in all pivotal clinical trials – Recognizes that biologic effects alone are not adequate to judge the overall effect of a treatment http://www.fda.gov/download ...
REGULATORY REQUIREMENTS FOR PREFORMULATION STUDIES
REGULATORY REQUIREMENTS FOR PREFORMULATION STUDIES

... the timing of anti microbial tests for preservatives E.g.: Japan does not accept phenol, where it is commonly used in US. The ...
Document
Document

... high-risk acute leukaemia and granted a Conditional Marketing Authorisation by the European Commission; NGR-hTNF is a novel therapeutic agent for solid tumours which displays antitumor activity through its specific binding to blood vessels feeding the cancer and to the concentration of immune system ...
TIPRANAVIR (Aptivus)
TIPRANAVIR (Aptivus)

... Many new copies of HIV are mutations. They are slightly different from the original virus. Some mutations can keep multiplying even when you are taking an ARV. When this happens, the drug will stop working. This is called “developing resistance” to the drug. See Fact Sheet 126 for more information o ...
Section 16-1 Genes and Variation (pages 393-396)
Section 16-1 Genes and Variation (pages 393-396)

... 10. Circle the letter of each choice that is true about mutations. a. They do not always change an amino acid. b. They always affect lengthy segments of a chromosome. c. They always affect an organism’s phenotype. d. They always affect an organism’s fitness. 11. Is the following sentence true or fal ...
RSC PPT Template - Royal Society of Chemistry
RSC PPT Template - Royal Society of Chemistry

... properties rather than unsatisfactory efficacy. In addition, the applications of parallel synthesis and combinatory chemistry to expedite lead finding and lead optimisation processes has shifted the chemical libraries towards ...
Ocular Adverse Effects Of Common Systemic Medications
Ocular Adverse Effects Of Common Systemic Medications

... subjective symptoms and objective corneal signs disappear. There is no relationship between the development of corneal deposits and the occurrence of retinopathy. Development of keratopathy does not contraindicate continued use of the drug. However if symptoms of haloes and glare bother the patient ...
Direct-to-Consumer Genetic Testing
Direct-to-Consumer Genetic Testing

... genome testing and family history. Genet Med 2014; 16(3):231-7 Heald B, Edelman E, Eng C. Prospective comparison of family medical history with personal genome screening for risk assessment of common cancers. Eur J Hum Genet 2012; 20(5):547-51 Hollands GJ, French DP, Griffin SJ, et al. The impact of ...
DIA 2013 Annual Meeting - Alliance for Safe Biologic Medicines
DIA 2013 Annual Meeting - Alliance for Safe Biologic Medicines

... Medical Concerns Regarding Potential Biologic Shortages • No two biologic medicines are identical and patients may respond to the differences. ...
heroin - a case
heroin - a case

... by police for drug offences rose from – 44 922 in 1990 – To 120 007 in 1999 ...
< 1 ... 1127 1128 1129 1130 1131 1132 1133 1134 1135 ... 1254 >

Pharmacogenomics

Pharmacogenomics (a portmanteau of pharmacology and genomics) is the study of the role of genetics in drug response. It deals with the influence of acquired and inherited genetic variation on drug response in patients by correlating gene expression or single-nucleotide polymorphisms with drug absorption, distribution, metabolism and elimination, as well as drug receptor target effects. The term pharmacogenomics is often used interchangeably with pharmacogenetics. Although both terms relate to drug response based on genetic influences, pharmacogenetics focuses on single drug-gene interactions, while pharmacogenomics encompasses a more genome-wide association approach, incorporating genomics and epigenetics while dealing with the effects of multiple genes on drug response.Pharmacogenomics aims to develop rational means to optimize drug therapy, with respect to the patients' genotype, to ensure maximum efficacy with minimal adverse effects. Through the utilization of pharmacogenomics, it is hoped that drug treatments can deviate from what is dubbed as the “one-dose-fits-all” approach. It attempts to eliminate the trial-and-error method of prescribing, allowing physicians to take into consideration their patient’s genes, the functionality of these genes, and how this may affect the efficacy of the patient’s current and/or future treatments (and where applicable, provide an explanation for the failure of past treatments). Such approaches promise the advent of ""personalized medicine""; in which drugs and drug combinations are optimized for each individual's unique genetic makeup. Whether used to explain a patient’s response or lack thereof to a treatment, or act as a predictive tool, it hopes to achieve better treatment outcomes, greater efficacy, minimization of the occurrence of drug toxicities and adverse drug reactions (ADRs). For patients who have lack of therapeutic response to a treatment, alternative therapies can be prescribed that would best suit their requirements. In order to provide pharmacogenomic-based recommendations for a given drug, two possible types of input can be used: genotyping or exome or whole genome sequencing. Sequencing provides many more data points, including detection of mutations that prematurely terminate the synthesized protein (early stop codon).
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report